An Institute Devoted to Translational Biomedical Research
Home | Contact | Links | 简体中文版
Keywords:
  About Us Research Graduate Education Cooperation and Exchange Translational Research System Technology Platforms Faculty and Staff Join Us  
Home  »  Translational Research System  »  Clinical Research Network
Clinical Research Network
 
 

Translational Research System

General Introduction
Clinical Research Network
 
Ruijin Hospital Affiliated with
Shanghai Jiao Tong University School of Medicine

Via collaborating with the Ruijin Hospital, we have established the largest cohort for diabetes research in China. Studies on innovative therapy of type II diabetes with traditional Chinese medicine have made significant progress. Ginsenosides has also been tested in a rat model of insulin resistance for its therapeutic efficacy. We also cooperated on the establishment of Chinese embryonic stem cell lines. The other major collaborative effort is on the understanding and treatment of leukemia.
Website: http://www.rjh.com.cn

Renji Hospital Affiliated with
Shanghai Jiao Tong University School of Medicine

Under the support of a Major Research Program of the Chinese Ministry of Science and Technology, we have cooperated with the Renji Hospital to perform basic and translational research on autoimmune diseases, aiming to developing novel targets and strategies for therapeutic intervention and biomarkers for individualized clinical management. The current major ongoing research projects include functional dissection of human lupus positional candidate genes, molecular mechanism of type I interferon pathway activation in lupus, role of the IFN-α targeted gene in lupus autoimmunity, microRNA and lupus autoimmunity and development of novel biomarkers for human lupus.
Website: http://www.renji.com

Xinhua Hospital Affiliated with
Shanghai Jiao Tong University School of Medicine

Collaborating with Xinhua hospital, we have generated human induced pluripotent stem cells (iPSCs) with high efficience using amniotic fluid-derived cells. This study identifies an ideal human somatic cell source for rapid and efficient generation of iPSCs, allowing us to explore more advanced approaches to establishing disease - or patient- specific iPSCs as well as to investigate the molecular mechanisms underlying somatic cell reprogramming.
Website: http://www.xinhuamed.com.cn

Shanghai Ninth People's Hospital Affiliated with
Shanghai Jiao Tong University School of Medicine

We have collaborated with the Department of Orthopedics to develop a novel composite graft combining enriched Bone Marrow Stem Cells (BMSCs) and porous β-tri calcium phosphate (β-TCP) for bone reconstruction. Patients with bone non-union, lumbar posterolateral fusion, fibrous dysplasia of bone and bone cyst disease have been treated with the new technique. The results show that enriched BMSCs have certain homogeneity without functional deterioration.
Website: http://www.9hospital.com

The First Affiliated Hospital of Soochow University
We have cooperated with the First Affiliated hospital of Soochow University to perform clinical studies using mesenchymal stem cells (MSCs) to treat liver failure and graft versus host disease (GVHD). Patients with liver cirrhosis and chronic liver diseases have been treated with MSCs and obtained promising results. Therefore, MSCs hold great potential for treating severe liver disease and GVHD.
Website: http://fyy.sdfyy.cn

The First People's Hospital of Changzhou /
The Third Affiliated Hospital of Soochow University

Collaborating with Changzhou First People's Hospital / the Third Affiliated Hospital of Soochow University, we have established a biomedical translational research base to explore a new model of medical research via cooperating with both laboratories and hospitals. We are striving to investigating tumor developmental mechanisms, clinical diagnosis strategies and cancer immunotherapy.
 
 
Copyright 2002-2016 The Institute of Health Sciences, SIBS, CAS / SJTUSM All Rights Reserved
225 South Chongqing Road, Shanghai, 200025 P.R. China Tel: 86-21-63847798 / 54923254 Fax: 86-21-63852579
Shanghai ICP #05033115